BowelScreen AustraliaTM is a pharmacy-based bowel cancer awareness, education and screening program for the Australian community using a clinically proven, sensitive and reliable immunochemical faecal occult blood test.
BowelScreen AustraliaTM is a collaboration between Bowel Cancer Australia and the Pharmacy Guild of Australia, with the support of Enterix Australia (manufacturer and accredited pathology laboratory for the InSure® immunochemical test).
The Pharmacy Guild of Australia is the national peak body representing community pharmacy. It seeks to serve the interests of its members and to support community pharmacy in its role delivering quality health outcomes for all Australians.
The Guild is committed to supporting and maintaining the community pharmacy model as the most appropriate and efficient system of delivering medicines, medication management and related services to the Australian public.
The 5,000 community pharmacies across Australia dispense around 250 million prescriptions annually. The vast majority of the prescriptions dispensed under the Federal Government’s subsidised Pharmaceutical Benefits Scheme (PBS) are available at the same price for all Australians wherever they live. This is a triumph of equity and access, which the Guild works hard to maintain.